The influence of statin use on breast density

被引:5
作者
Boudreau, Denise M. [1 ]
Rutter, Carolyn M. [1 ]
Buist, Diana S. M. [1 ]
机构
[1] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
关键词
D O I
10.1158/1055-9965.EPI-05-0802
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To evaluate if 3-hydroxy-3-methylglutaryl CoA reductase reductase inhibitor use (statins) alters mammography measured breast density. Methods: Cohort study of women ages 50 to 80 years with two mammography screenings. Changes in BI-RADS breast density between screenings was compared for nonusers, initiators, discontinuers, continuers, and any users of statins. Results: Statin use was not associated with increases or decreases in breast density compared with nonusers after adjusting for age, body mass index, change in body mass index, hormone therapy use, and time between screenings. Cumulative days of statin use during the year before screening was not associated with changes in breast density in any of the groups of statin users. When hormone therapy users were excluded, any statin use was associated with an increase in breast density compared with nonusers (odds ratio, 1.2; 95% confidence interval, 1.0-1.5). Conclusions: We found no association between statin use and change in breast density in general, but statin use may be associated with increases in breast density among nonusers of hormone therapy.
引用
收藏
页码:1026 / 1029
页数:4
相关论文
共 25 条
[1]   Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women [J].
Aiello, EJ ;
Tworoger, SS ;
Yasui, Y ;
Stanczyk, FZ ;
Potter, J ;
Ulrich, CM ;
Irwin, M ;
McTiernan, A .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (06) :1411-1417
[2]   Statin use and the risk of breast cancer [J].
Beck, P ;
Wysowski, DK ;
Downey, W ;
Butler-Jones, D .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (03) :280-285
[3]   Breast imaging reporting and data system: Inter- and intraobserver variability in feature analysis and final assessment [J].
Berg, WA ;
Campassi, C ;
Langenberg, P ;
Sexton, MJ .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (06) :1769-1777
[4]   Impact of healthcare delivery system on where HMO-enrolled seniors purchase medication [J].
Boudreau, DM ;
Doescher, MP ;
Jackson, JE ;
Fishman, PA .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (7-8) :1317-1318
[5]   The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women - A case-control study [J].
Boudreau, DM ;
Gardner, JS ;
Malone, KE ;
Heckbert, SR ;
Blough, DK ;
Daling, JR .
CANCER, 2004, 100 (11) :2308-2316
[6]  
BOYD NF, 1995, CANCER EPIDEM BIOMAR, V4, P727
[7]   QUANTITATIVE CLASSIFICATION OF MAMMOGRAPHIC DENSITIES AND BREAST-CANCER RISK - RESULTS FROM THE CANADIAN NATIONAL BREAST SCREENING STUDY [J].
BOYD, NF ;
BYNG, JW ;
JONG, RA ;
FISHELL, EK ;
LITTLE, LE ;
MILLER, AB ;
LOCKWOOD, GA ;
TRITCHLER, DL ;
YAFFE, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) :670-675
[8]  
Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008
[9]   Lipid-lowering drug use and breast cancer in older women: A prospective study [J].
Cauley, JA ;
Zmuda, JM ;
Lui, LY ;
Hillier, TA ;
Ness, RB ;
Stone, KL ;
Cummings, SR ;
Bauer, DC .
JOURNAL OF WOMENS HEALTH, 2003, 12 (08) :749-756
[10]  
Chan KKW, 2003, CLIN CANCER RES, V9, P10